TY - JOUR
T1 - General Versus Nongeneral Anesthesia for Middle Meningeal Artery Embolization for Chronic Subdural Hematomas
T2 - Multicenter Propensity Score Matched Study
AU - Salem, Mohamed M.
AU - Sioutas, Georgios S.
AU - Khalife, Jane
AU - Kuybu, Okkes
AU - Caroll, Kate
AU - Hoang, Alex Nguyen
AU - Baig, Ammad A.
AU - Salih, Mira
AU - Khorasanizadeh, Mirhojjat
AU - Baker, Cordell
AU - Mendez, Aldo A.
AU - Cortez, Gustavo
AU - Abecassis, Zachary A.
AU - Ruiz Rodriguez, Juan F.
AU - Davies, Jason M.
AU - Narayanan, Sandra
AU - Cawley, C. Michael
AU - Riina, Howard A.
AU - Moore, Justin M.
AU - Spiotta, Alejandro M.
AU - Khalessi, Alexander A.
AU - Howard, Brian M.
AU - Hanel, Ricardo
AU - Tanweer, Omar
AU - Tonetti, Daniel A.
AU - Siddiqui, Adnan H.
AU - Lang, Michael J.
AU - Levy, Elad I.
AU - Kan, Peter
AU - Jovin, Tudor
AU - Grandhi, Ramesh
AU - Srinivasan, Visish M.
AU - Ogilvy, Christopher S.
AU - Gross, Bradley A.
AU - Jankowitz, Brian T.
AU - Thomas, Ajith J.
AU - Levitt, Michael R.
AU - Burkhardt, Jan Karl
N1 - Publisher Copyright:
© Congress of Neurological Surgeons 2024.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - BACKGROUND AND OBJECTIVES: The choice of anesthesia type (general anesthesia [GA] vs nongeneral anesthesia [non-GA]) in middle meningeal artery embolization (MMAE) procedures for chronic subdural hematomas (cSDH) differs between institutions and left to care team discretion given lack of standard guidelines. We compare the outcomes of GA vs non-GA in MMAE. METHODS: Consecutive patients receiving MMAE for cSDH at 14 North American centers (2018-2023) were included. Clinical, cSDH characteristics, and technical/clinical outcomes were compared between the GA/non-GA groups. Using propensity score matching (PSM), patients were matched controlling for age, baseline modified Rankin Scale, concurrent/prior surgery, hematoma thickness/midline shift, and baseline antiplatelet/anticoagulation. The primary end points included surgical rescue and radiographic success rates (≥50% reduction in maximum hematoma thickness with minimum 2 weeks of imaging). Secondary end points included technical feasibility, procedural complications, and functional outcomes. RESULTS: Seven hundred seventy-eight patients (median age 73 years, 73.2% male patients) underwent 956 MMAE procedures, 667 (70.4%) were non-GA and 280 were GA (29.6%). After running 1:3 PSM algorithm, this resulted in 153 and 296 in the GA and non-GA groups, respectively. There were no baseline/procedural differences between the groups except radial access more significantly used in the non-GA group (P = .001). There was no difference between the groups in procedural technical feasibility, complications rate, length of stay, surgical rescue rates, or favorable functional outcome at the last follow-up. Subsequent 1:1 sensitivity PSM retained the same results. Bilateral MMAE procedures were more performed under non-GA group (75.8% vs 67.2%; P = .01); no differences were noted in clinical/radiographic outcomes between bilateral vs unilateral MMAE, except for longer procedure duration in the bilateral group (median 73 minutes [IQR 48.3-100] vs 54 minutes [39-75]; P < .0001). Another PSM analysis comparing GA vs non-GA in patients undergoing stand-alone MMAE retained similar associations. CONCLUSION: We found no significant differences in radiological improvement/clinical outcomes between GA and non-GA for MMAE.
AB - BACKGROUND AND OBJECTIVES: The choice of anesthesia type (general anesthesia [GA] vs nongeneral anesthesia [non-GA]) in middle meningeal artery embolization (MMAE) procedures for chronic subdural hematomas (cSDH) differs between institutions and left to care team discretion given lack of standard guidelines. We compare the outcomes of GA vs non-GA in MMAE. METHODS: Consecutive patients receiving MMAE for cSDH at 14 North American centers (2018-2023) were included. Clinical, cSDH characteristics, and technical/clinical outcomes were compared between the GA/non-GA groups. Using propensity score matching (PSM), patients were matched controlling for age, baseline modified Rankin Scale, concurrent/prior surgery, hematoma thickness/midline shift, and baseline antiplatelet/anticoagulation. The primary end points included surgical rescue and radiographic success rates (≥50% reduction in maximum hematoma thickness with minimum 2 weeks of imaging). Secondary end points included technical feasibility, procedural complications, and functional outcomes. RESULTS: Seven hundred seventy-eight patients (median age 73 years, 73.2% male patients) underwent 956 MMAE procedures, 667 (70.4%) were non-GA and 280 were GA (29.6%). After running 1:3 PSM algorithm, this resulted in 153 and 296 in the GA and non-GA groups, respectively. There were no baseline/procedural differences between the groups except radial access more significantly used in the non-GA group (P = .001). There was no difference between the groups in procedural technical feasibility, complications rate, length of stay, surgical rescue rates, or favorable functional outcome at the last follow-up. Subsequent 1:1 sensitivity PSM retained the same results. Bilateral MMAE procedures were more performed under non-GA group (75.8% vs 67.2%; P = .01); no differences were noted in clinical/radiographic outcomes between bilateral vs unilateral MMAE, except for longer procedure duration in the bilateral group (median 73 minutes [IQR 48.3-100] vs 54 minutes [39-75]; P < .0001). Another PSM analysis comparing GA vs non-GA in patients undergoing stand-alone MMAE retained similar associations. CONCLUSION: We found no significant differences in radiological improvement/clinical outcomes between GA and non-GA for MMAE.
KW - Conscious sedation
KW - General
KW - Middle meningeal artery embolization
KW - Monitored anesthesia care
KW - cSDH
UR - http://www.scopus.com/inward/record.url?scp=85198754277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85198754277&partnerID=8YFLogxK
U2 - 10.1227/neu.0000000000002874
DO - 10.1227/neu.0000000000002874
M3 - Article
C2 - 38412228
AN - SCOPUS:85198754277
SN - 0148-396X
VL - 95
SP - 76
EP - 86
JO - Neurosurgery
JF - Neurosurgery
IS - 1
ER -